SCHEMBL19921983

SCHEMBL19921983

C[C@H](C=O)c1ccccc1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
ALOX15 P16050 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 1/20 0.47
MAPT P10636 2/20 0.45
HDAC8 Q9BY41 1/20 0.45
KDM4E B2RXH2 3/20 0.42
HPGD P15428 3/20 0.42
CA12 O43570 3/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA4 P22748 3/20 0.42
CA7 P43166 3/20 0.42
CA9 Q16790 3/20 0.42
HMGB1 P09429 2/20 0.42
NAPRT Q6XQN6 2/20 0.42
CA6 P23280 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2220688 1.00 ALDH1A1 (0.48) ALDH1A1ALOX15TDP1GAAKMT2A
SCHEMBL9717389 0.87 ALDH1A1 (0.44) ALDH1A1ALOX15TDP1GAAKMT2A
SCHEMBL20606888 0.83 IRAK4 (0.47) ALDH1A1GAAMAPTKDM4EHPGD
SCHEMBL27961101 0.83 ALDH1A1 (0.46) ALDH1A1ALOX15TDP1GAAKMT2A
SCHEMBL254364 0.81 ALDH1A1 (0.59) ALDH1A1ALOX15TDP1GAAKMT2A
Hydrogen Peroxide SCHEMBL9514730 0.81 ALDH1A1 (0.59) ALDH1A1ALOX15TDP1GAAKMT2A
SCHEMBL134091 0.81 ALDH1A1 (0.59) ALDH1A1ALOX15TDP1GAAKMT2A
Benzene SCHEMBL28132022 0.81 ALDH1A1 (0.59) ALDH1A1ALOX15TDP1GAAKMT2A
SCHEMBL29657201 0.81 ALDH1A1 (0.59) ALDH1A1ALOX15TDP1GAAKMT2A
Ammonia Solution, Strong SCHEMBL11877644 0.79 ALDH1A1 (0.56) ALDH1A1ALOX15TDP1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107743491-B Novel oxathiolanecarboxylic acids and derivatives thereof for the treatment and prevention of viral infections 豪夫迈·罗氏有限公司 2020-08-21 CN disclosed
US-10183954-B2 Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection HOFFMANN-LA ROCHE INC. (US) 2019-01-22 US disclosed
US-20180065991-A1 NOVEL OXATHIOLANE CARBOXYLIC ACIDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065991-A1 NOVEL OXATHIOLANE CARBOXYLIC ACIDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION CXCR1, CCR1, SLC7A1 ALDH1A1 23/4885ALOX15 579/4885TDP1 2353/4885
US-10183954-B2 Oxathiolane carboxylic acids and derivatives for the treatment and prophylaxis of virus infection CXCR1, CCR1, HAVCR2 ALDH1A1 16/4885ALOX15 618/4885TDP1 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.